1/25/2012

Canada-based Algae Biosciences plans to commercialize algal omega-3 fatty acids by April instead of its target of this month. The company's bioreactor is above an underground salt dome and aquifer. The result is expected to be novel EPA/DHA-rich oils.

Full Story:
NutraIngredients

Related Summaries